Inventor · disambiguated record
Matthew C. Franklin
Also filed as: FRANKLIN MATTHEW · FRANKLIN MATTHEW C
9 granted patents·8 pending applications·41 citations·filing 2003–2024
88Inventor score
Top patents by PatentIndex Score
17 records- 0197US11407813B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2021·Granted Aug 9, 2022·3 cites·20 claims
- 0294US11505594B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2022·Granted Nov 22, 2022·1 cites·27 claims
- 0394US11180540B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2020·Granted Nov 23, 2021·2 cites·28 claims
- 0493US11098311B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2020·Granted Aug 24, 2021·2 cites·18 claims
- 0591US11440950B2Anti-VEGF protein compositions and methods for producing the sameREGENERON PHARMA·Filed 2021·Granted Sep 13, 2022·1 cites·24 claims
- 0690US10806780B2Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereofREGENERON PHARMA·Filed 2018·Granted Oct 20, 2020·4 cites·17 claims
- 0784US11559576B2Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereofREGENERON PHARMA·Filed 2020·Granted Jan 24, 2023·1 cites·23 claims
- 0883US2025064913A1Anti-human papillomavirus (hpv) antigen-binding proteins and methods of use thereofREGENERON PHARMA·Filed 2024·Application pending·0 cites
- 0982US7067274B2Compositions and methods for the screening pro-apoptotic compoundsBURNHAM INST·Filed 2004·Granted Jun 27, 2006·27 cites·4 claims
- 1080US12115216B2Anti-human papillomavirus (HPV) antigen-binding proteins and methods of use thereofREGENERON PHARMA·Filed 2022·Granted Oct 15, 2024·0 cites·19 claims
- 1166US2009148921A1Compositions and methods for enhancing apoptosisGENENTECH INC·Filed 2006·Application pending·0 cites
- 1260US2004171554A1Compositions and methods for enhancing apoptosisGENENTECH INC·Filed 2003·Application pending·0 cites
- 1359US2013143824A1Compositions and methods for enhancing apoptosisGENENTECH INC·Filed 2012·Application pending·0 cites
- 1455US2012058953A1Compositions and methods for enhancing apoptosisDESHAYES KURT·Filed 2011·Application pending·0 cites
- 1554US2023063116A1Vegf mini-traps and method of use thereofREGENERON PHARMA·Filed 2020·Application pending·0 cites
- 1653US2011039324A1Compositions and methods for enhancing apoptosisGENENTECH INC·Filed 2010·Application pending·0 cites
- 1752US2006246471A1Compositions and methods for screening pro-apoptotic compoundsBURNHAM INST·Filed 2005·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Matthew C. Franklin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →